Hepatocellular carcinoma classification: Difference between revisions
Usama Talib (talk | contribs) No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Hepatocellular carcinoma}} | {{Hepatocellular carcinoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {SH} | ||
==Overview== | ==Overview== | ||
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4]. | [Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4]. | ||
| Line 34: | Line 31: | ||
==Classification== | ==Classification== | ||
* | *Hepatocellular carcinoma may be classified according to the histological subtypes: | ||
**Fibrolamellar carcinoma sarcomatoid HCC | |||
**Undifferentiated carcinoma | |||
** | **Combined HCC-cholangiocarcinoma (HCC-CC) | ||
** | **Lymphoepithelioma | ||
** | |||
** | |||
*If the staging system involves specific and characteristic findings and features: | *If the staging system involves specific and characteristic findings and features: | ||
*According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2]. | *According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2]. | ||
Revision as of 04:44, 27 December 2017
|
Hepatocellular carcinoma Microchapters |
|
Differentiating Hepatocellular carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatocellular carcinoma classification On the Web |
|
American Roentgen Ray Society Images of Hepatocellular carcinoma classification |
|
Risk calculators and risk factors for Hepatocellular carcinoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: {SH}
Overview
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
OR
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
Classification
- Hepatocellular carcinoma may be classified according to the histological subtypes:
- Fibrolamellar carcinoma sarcomatoid HCC
- Undifferentiated carcinoma
- Combined HCC-cholangiocarcinoma (HCC-CC)
- Lymphoepithelioma
- If the staging system involves specific and characteristic findings and features:
- According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
- The staging of [malignancy name] is based on the [staging system].
OR
- There is no established system for the staging of [malignancy name].